Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

P-Sam

Other

Phase 2 Most advanced trial

What is P-Sam?

P-Sam is an investigational drug studied in Adenoid Cystic Carcinoma.

At a glance

Drug type
Other
Therapy area
Oncology
In trials of
AZN
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 2

Conditions studied

Adenoid Cystic Carcinoma

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.